Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Pertsemlidis

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Clinical Investigation|August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionYoung-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Cancer Research|September 17, 2005
Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trapDeborah A Ferguson, Matthew R Muenster, Qun Zang, et al.
Plos One|January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganizationJ Saadi Imam, Jason R Plyler, Hima Bansal, et al.
Nucleic Acids Research|November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cellsAruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
European Journal of Medicinal Chemistry|May 25, 2016
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cellsSean Henry, Ria Kidner, Mary R Reisenauer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Clinical Investigation|August 2, 2012
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionYoung-Ho Ahn, Don L Gibbons, Deepavali Chakravarti, et al.
Cancer Research|September 17, 2005
Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trapDeborah A Ferguson, Matthew R Muenster, Qun Zang, et al.
Plos One|January 4, 2013
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganizationJ Saadi Imam, Jason R Plyler, Hima Bansal, et al.
Nucleic Acids Research|November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cellsAruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
European Journal of Medicinal Chemistry|May 25, 2016
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cellsSean Henry, Ria Kidner, Mary R Reisenauer, et al.
Pageof 6